[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR0102186A - Use of product comprising catuama extract as antithromboembolic agent, pharmaceutical composition comprising such product for treatment or prevention of thromboembolic disorders, method for treating thromboembolic disorders using said product and use of said product for producing a pharmaceutical composition for treating or preventing thromboembolic disorders - Google Patents

Use of product comprising catuama extract as antithromboembolic agent, pharmaceutical composition comprising such product for treatment or prevention of thromboembolic disorders, method for treating thromboembolic disorders using said product and use of said product for producing a pharmaceutical composition for treating or preventing thromboembolic disorders

Info

Publication number
BR0102186A
BR0102186A BR0102186-9A BR0102186A BR0102186A BR 0102186 A BR0102186 A BR 0102186A BR 0102186 A BR0102186 A BR 0102186A BR 0102186 A BR0102186 A BR 0102186A
Authority
BR
Brazil
Prior art keywords
product
thromboembolic disorders
pharmaceutical composition
treating
treatment
Prior art date
Application number
BR0102186-9A
Other languages
Portuguese (pt)
Inventor
Osvaldo Silva Jr
Tadafissa Fujii
Joao Batista Calixto
Daniela De Almeida Cabrini
Alessandra Beirith
Elizabeth Soares Fernandes
Original Assignee
Catarinense S A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catarinense S A Lab filed Critical Catarinense S A Lab
Priority to BR0102186-9A priority Critical patent/BR0102186A/en
Priority to PCT/BR2001/000093 priority patent/WO2002096443A1/en
Publication of BR0102186A publication Critical patent/BR0102186A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"USO DE PRODUTO COMPREENDENDO EXTRATO DE CATUAMA COMO AGENTE ANTITROMBOEMBóLICO, COMPOSIçãO FARMACEUTICA COMPREENDENDO TAL PRODUTO PARA TRATAMENTO OU PREVENçãO DE DISTúRBIOS TROMBOEMBóLICOS, MéTODO PARA TRATAMENTO DE DISTúRBIOS TROMBOEMBóLICOS USANDO O REFERIDO PRODUTO E USO DO REFERIDO PRODUTO PARA PRODUçãO DE UMA COMPOSIçãO FARMACêUTICA PARA TRATAMENTO OU PREVENçãO DE DISTúRBIOS TROMBOEMBóLICOS". A invenção trata do uso de um produto de extratos de Catuama compreendendo as espécies Trichilia sp (preferencialmente da espécie catigua), Paullinia cupana (Sapindaceae), Fltychopetalum olacoides (Oiacaceae) e Zingiber officinale (Zingiberaceae), caracterizado pelo fato de ser um agente anti-tromboembólico. Um produto particularmente abrangido pelo escopo da invenção é o extrato de Catuama comercialmente disponível como Catuama^ <32>^."UNDERSTANDING PRODUCT USE Catuama EXTRACT AS AGENT ANTITROMBOEMBóLICO, PHARMACEUTICAL COMPOSITION COMPRISING SUCH PRODUCT FOR TREATMENT OR DISORDERS PREVENTION thromboembolic, METHOD FOR DISORDERS TREATMENT thromboembolic USING SUCH PRODUCT AND REFERRED TO USE PRODUCT FOR THE PRODUCTION PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION TROMBOEMBOX DISORDERS ". The invention relates to the use of a product of Catuama extracts comprising Trichilia sp (preferably catigua), Paullinia cupana (Sapindaceae), Fltychopetalum olacoides (Oiacaceae) and Zingiber officinale (Zingiberaceae) species. -thromboembolic. One product particularly within the scope of the invention is Catuama extract commercially available as Catuama®.

BR0102186-9A 2001-05-30 2001-05-30 Use of product comprising catuama extract as antithromboembolic agent, pharmaceutical composition comprising such product for treatment or prevention of thromboembolic disorders, method for treating thromboembolic disorders using said product and use of said product for producing a pharmaceutical composition for treating or preventing thromboembolic disorders BR0102186A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BR0102186-9A BR0102186A (en) 2001-05-30 2001-05-30 Use of product comprising catuama extract as antithromboembolic agent, pharmaceutical composition comprising such product for treatment or prevention of thromboembolic disorders, method for treating thromboembolic disorders using said product and use of said product for producing a pharmaceutical composition for treating or preventing thromboembolic disorders
PCT/BR2001/000093 WO2002096443A1 (en) 2001-05-30 2001-07-31 Use of a product comprising catuama extract as an antithromboembolic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0102186-9A BR0102186A (en) 2001-05-30 2001-05-30 Use of product comprising catuama extract as antithromboembolic agent, pharmaceutical composition comprising such product for treatment or prevention of thromboembolic disorders, method for treating thromboembolic disorders using said product and use of said product for producing a pharmaceutical composition for treating or preventing thromboembolic disorders

Publications (1)

Publication Number Publication Date
BR0102186A true BR0102186A (en) 2003-02-18

Family

ID=3947381

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0102186-9A BR0102186A (en) 2001-05-30 2001-05-30 Use of product comprising catuama extract as antithromboembolic agent, pharmaceutical composition comprising such product for treatment or prevention of thromboembolic disorders, method for treating thromboembolic disorders using said product and use of said product for producing a pharmaceutical composition for treating or preventing thromboembolic disorders

Country Status (2)

Country Link
BR (1) BR0102186A (en)
WO (1) WO2002096443A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0302750A (en) 2003-08-08 2005-03-29 Catarinense S A Lab Product use comprising plant material of the species trichilia sp. associated or not for the reversal / combat of ventricular fibrillation; pharmaceutical composition comprising said plant material for reversing / combating ventricular fibrillation; method for reversing / combating ventricular fibrillation using said plant material; use of said plant material for the production of a pharmaceutical composition for reversing / combating ventricular fibrillation
WO2007016756A1 (en) * 2005-08-08 2007-02-15 Lendar Do Brasil S.A. Pharmaceutical compositions containing plant extracts, use of pharmaceutical compositions and method of treatment
RU2653468C2 (en) * 2015-12-31 2018-05-08 федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации Pharmaceutical composition, made of vicia abbreviata herb used as endotelyoprotective agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9703946A (en) * 1997-07-10 1999-03-09 Catarinense S A Lab Use of selected plant material of the trichilia species for the preparation of pharmaceutical formulations and pharmaceutical compositions containing said plant material

Also Published As

Publication number Publication date
WO2002096443A1 (en) 2002-12-05

Similar Documents

Publication Publication Date Title
BR0214962A (en) Composition for treating neurocerebrovascular disorders
BR0207760A (en) Pharmaceutical composition, use thereof, methods for treating pain and inflammation, and process for preparing a composition
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
AU2002231544A1 (en) Therapeutic uses of herbal compositions
HK1060834A1 (en) Composition and method for smoke detoxification
GB0129260D0 (en) Pharmaceutical compositions and their uses
DK2263480T3 (en) Composition for promoting bone growth and maintaining bone health, including Mentha extracts
BR0108940A (en) Enhanced herbal composition that features antiallergic properties and preparation process
GEP20053510B (en) Substituted Pyrrolopyridinone Derivatives Useful as Phosphodiesterase Inhibitors
BR0306258A (en) Composition, method for hair treatment and method for maintaining the shape and / or definition of hair curling
ATE318610T1 (en) ORAL COMPOSITIONS FOR TREATING SCALP DISEASES
BG105275A (en) Tan-1057 derivatives
BR0309406A (en) Pharmaceutical composition, preparation process, kit and methods for treating obesity, use of lipase composition and inhibitor, lipase inhibitor and glucomannan or konjac and their use and method of treatment
BR0102186A (en) Use of product comprising catuama extract as antithromboembolic agent, pharmaceutical composition comprising such product for treatment or prevention of thromboembolic disorders, method for treating thromboembolic disorders using said product and use of said product for producing a pharmaceutical composition for treating or preventing thromboembolic disorders
BR0102184A (en) Use of product comprising catuama extract as an antidepressant agent and in anxiety disorders, pharmaceutical composition comprising such product for treating or preventing depression and / or anxiety disorders, method for treating or preventing depression and / or anxiety disorders using said product and use of said product for producing a pharmaceutical composition for treating or preventing depression and / or anxiety disorders
BRPI0102184B8 (en) use of a catuama extract product
WO2022065970A3 (en) Composition comprising natural product mixed extract for prevention or treatment of coronavirus infection
BR0102185A (en) Use of product comprising catuama extract as an antioxidant or cerebral vasodilating agent, pharmaceutical composition comprising such product for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals, method for the prophylaxis or treatment of cerebral vascular disorders and disorders caused by improper pressing of free radicals using said product and use of said product for the production of a pharmaceutical composition, for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals
GB2426453A (en) A synergistic composition for treating hyperlipidemia
ATE437646T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING PLANT MATERIAL FROM TRICHILIA SPP. ALONE OR IN CONJUNCTION WITH OTHER PLANT EXTRACTS FOR THE TREATMENT AND/OR PREVENTION OF VENTRIC FIBERILITY
BR0214959A (en) Pharmaceutical composition for the prevention and treatment of premature ejaculation and / or sexual stimulation hypersensitivity
AU2001276437A1 (en) Use of polysulphated cyclodextrins for treating osteoarthritis
WO2002046163A3 (en) Quinoline derivatives and their use as anti-epileptics
BRPI0414223A (en) use of gentiana lutea extracts as an antimicrobial agent
ZA202209623B (en) A pharmaceutical composition and method of treatment using serratiopeptidase, mannose or its derivative, and optionally antinfection agents

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07D Technical examination (opinion) related to article 229 of industrial property law
B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O C/C 11, 8O C/C 13, 10 E 25 DA LPI.

B09B Decision: refusal

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

B15K Others concerning applications: alteration of classification

Ipc: A61K 36/185 (2006.01), A61K 36/58 (2006.01), A61K